Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.890 USD
−19.51 M USD
0.00 USD
13.79 M
About Imunon, Inc.
Sector
Industry
CEO
Stacy R. Lindborg
Website
Headquarters
Lawrenceville
Founded
1982
FIGI
BBG00JRYCWD6
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0HUZ is 0.860 USD — it has increased by 2.20% in the past 24 hours. Watch IMUNON INC COM USD0.01 (POST REV SPLT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange IMUNON INC COM USD0.01 (POST REV SPLT) stocks are traded under the ticker 0HUZ.
0HUZ stock has risen by 1.44% compared to the previous week, the month change is a 27.05% rise, over the last year IMUNON INC COM USD0.01 (POST REV SPLT) has showed a −3.90% decrease.
We've gathered analysts' opinions on IMUNON INC COM USD0.01 (POST REV SPLT) future price: according to them, 0HUZ price has a max estimate of 29.00 USD and a min estimate of 5.00 USD. Watch 0HUZ chart and read a more detailed IMUNON INC COM USD0.01 (POST REV SPLT) stock forecast: see what analysts think of IMUNON INC COM USD0.01 (POST REV SPLT) and suggest that you do with its stocks.
0HUZ reached its all-time high on Jun 24, 2020 with the price of 63.000 USD, and its all-time low was 0.495 USD and was reached on Feb 13, 2024. View more price dynamics on 0HUZ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0HUZ stock is 2.37% volatile and has beta coefficient of 1.87. Track IMUNON INC COM USD0.01 (POST REV SPLT) stock price on the chart and check out the list of the most volatile stocks — is IMUNON INC COM USD0.01 (POST REV SPLT) there?
Today IMUNON INC COM USD0.01 (POST REV SPLT) has the market capitalization of 12.04 M, it has decreased by −6.56% over the last week.
Yes, you can track IMUNON INC COM USD0.01 (POST REV SPLT) financials in yearly and quarterly reports right on TradingView.
IMUNON INC COM USD0.01 (POST REV SPLT) is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
0HUZ earnings for the last quarter are −0.34 USD per share, whereas the estimation was −0.39 USD resulting in a 12.37% surprise. The estimated earnings for the next quarter are −0.36 USD per share. See more details about IMUNON INC COM USD0.01 (POST REV SPLT) earnings.
IMUNON INC COM USD0.01 (POST REV SPLT) revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
0HUZ net income for the last quarter is −4.85 M USD, while the quarter before that showed −4.79 M USD of net income which accounts for −1.20% change. Track more IMUNON INC COM USD0.01 (POST REV SPLT) financial stats to get the full picture.
No, 0HUZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 33.00 employees. See our rating of the largest employees — is IMUNON INC COM USD0.01 (POST REV SPLT) on this list?
Like other stocks, 0HUZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMUNON INC COM USD0.01 (POST REV SPLT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMUNON INC COM USD0.01 (POST REV SPLT) technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMUNON INC COM USD0.01 (POST REV SPLT) stock shows the sell signal. See more of IMUNON INC COM USD0.01 (POST REV SPLT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.